Literature DB >> 30834445

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Timothy M Uyeki1, Henry H Bernstein2, John S Bradley3,4, Janet A Englund5, Thomas M File6, Alicia M Fry1, Stefan Gravenstein7, Frederick G Hayden8, Scott A Harper9, Jon Mark Hirshon10, Michael G Ison11, B Lynn Johnston12, Shandra L Knight13, Allison McGeer14, Laura E Riley15, Cameron R Wolfe16, Paul E Alexander17,18, Andrew T Pavia19.   

Abstract

Entities:  

Keywords:  chemoprophylaxis; diagnostic testing; influenza; institutional outbreaks; seasonal; treatment

Mesh：

Year:  2019        PMID： 30834445      PMCID： PMC6769232          DOI： 10.1093/cid/ciy874

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  16 in total

1.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

2.  Estimating influenza-associated deaths in the United States.

Authors:  William W Thompson; Matthew R Moore; Eric Weintraub; Po-Yung Cheng; Xiaoping Jin; Carolyn B Bridges; Joseph S Bresee; David K Shay
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Seasonal Incidence of Symptomatic Influenza in the United States.

Authors:  Jerome I Tokars; Sonja J Olsen; Carrie Reed
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

4.  Impact of rapid diagnosis on management of adults hospitalized with influenza.

Authors:  Ann R Falsey; Yoshihiko Murata; Edward E Walsh
Journal:  Arch Intern Med       Date:  2007-01-22

5.  The underrecognized burden of influenza in young children.

Authors:  Katherine A Poehling; Kathryn M Edwards; Geoffrey A Weinberg; Peter Szilagyi; Mary Allen Staat; Marika K Iwane; Carolyn B Bridges; Carlos G Grijalva; Yuwei Zhu; David I Bernstein; Guillermo Herrera; Dean Erdman; Caroline B Hall; Ranee Seither; Marie R Griffin
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

6.  Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

Authors:  Hong Zhou; William W Thompson; Cecile G Viboud; Corinne M Ringholz; Po-Yung Cheng; Claudia Steiner; Glen R Abedi; Larry J Anderson; Lynnette Brammer; David K Shay
Journal:  Clin Infect Dis       Date:  2012-04-10       Impact factor: 9.079

7.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

8.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

Review 9.  Neuraminidase inhibitors for preventing and treating influenza in adults and children.

Authors:  Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Rokuro Hama; Matthew J Thompson; Elizabeth A Spencer; Igho Onakpoya; Kamal R Mahtani; David Nunan; Jeremy Howick; Carl J Heneghan
Journal:  Cochrane Database Syst Rev       Date:  2014-04-10

Review 10.  Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.

Authors:  Stella G Muthuri; Puja R Myles; Sudhir Venkatesan; Jo Leonardi-Bee; Jonathan S Nguyen-Van-Tam
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226
View more
  66 in total

1.  Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza.

Authors:  Michael G Ison; Jeffrey A Linder
Journal:  Clin Infect Dis       Date:  2021-02-16       Impact factor: 9.079

2.  Association of physician experience with a higher prescription rate of anti-influenza agents in low-risk patients.

Authors:  Koji Nakajima; Hiroyuki Akebo; Yukio Tsugihashi; Hiroyasu Ishimaru; Ryuichi Sada
Journal:  Intern Emerg Med       Date:  2021-01-02       Impact factor: 3.397

3.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 4.  Forty Years of Molecular Diagnostics for Infectious Diseases.

Authors:  Jonathan E Schmitz; Charles W Stratton; David H Persing; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2022-07-19       Impact factor: 11.677

5.  Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations.

Authors:  James C King; John H Beigel; Michael G Ison; Richard E Rothman; Timothy M Uyeki; Robert E Walker; James D Neaton; John S Tegeris; James A Zhou; Kimberly L Armstrong; Wendy Carter; Peter S Miele; Melissa S Willis; Andrea F Dugas; LaRee A Tracy; David M Vock; Rick A Bright
Journal:  Open Forum Infect Dis       Date:  2019-03-14       Impact factor: 3.835

6.  Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Authors:  Emily T Martin; Caroline Cheng; Joshua G Petrie; Elif Alyanak; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Arnold S Monto; Christopher Trabue; H Keipp Talbot; Jill M Ferdinands
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

7.  Performance of Diagnostic Model for Differentiating Between COVID-19 and Influenza: A 2-Center Retrospective Study.

Authors:  Jingwen Li; Simin Li; Xiaoming Qiu; Wenyan Zhu; Linfeng Li; Bo Qin
Journal:  Med Sci Monit       Date:  2021-05-12

8.  Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic.

Authors:  Santiago Grau; Daniel Echeverria-Esnal; Silvia Gómez-Zorrilla; Maria Eugenia Navarrete-Rouco; Joan Ramon Masclans; Merce Espona; Maria Pilar Gracia-Arnillas; Xavier Duran; Merce Comas; Juan Pablo Horcajada; Olivia Ferrández
Journal:  Antibiotics (Basel)       Date:  2021-01-29

9.  Severe Acute Respiratory Infection Surveillance during the Initial Phase of the COVID-19 Outbreak in North India: A Comparison of COVID-19 to Other SARI Causes.

Authors:  Ashok K Pannu; Mohan Kumar; Pranjal Singh; Alan Shaji; Arnab Ghosh; Ashish Behera; Saurabh C Sharda; Mandeep Bhatia; Neeraj Singla; Deba P Dhibar; Mini P Singh; Navneet Sharma; Atul Saroch
Journal:  Indian J Crit Care Med       Date:  2021-07

10.  Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned.

Authors:  Lars Dölken; August Stich; Christoph D Spinner
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.